RU2001135360A - METHOD FOR DETERMINING AN ORGANISM RESISTANCE - Google Patents

METHOD FOR DETERMINING AN ORGANISM RESISTANCE

Info

Publication number
RU2001135360A
RU2001135360A RU2001135360/14A RU2001135360A RU2001135360A RU 2001135360 A RU2001135360 A RU 2001135360A RU 2001135360/14 A RU2001135360/14 A RU 2001135360/14A RU 2001135360 A RU2001135360 A RU 2001135360A RU 2001135360 A RU2001135360 A RU 2001135360A
Authority
RU
Russia
Prior art keywords
ipc
determining
resistance
zone
organism resistance
Prior art date
Application number
RU2001135360/14A
Other languages
Russian (ru)
Other versions
RU2226689C2 (en
Inventor
Валерий Филиппович Лопатин
Роман Валерьевич Лопатин
Николай Григорьевич Горбушин
Юрий Станиславович Мардынский
Original Assignee
Медицинский радиологический научный центр РАМН
Filing date
Publication date
Application filed by Медицинский радиологический научный центр РАМН filed Critical Медицинский радиологический научный центр РАМН
Priority to RU2001135360/14A priority Critical patent/RU2226689C2/en
Priority claimed from RU2001135360/14A external-priority patent/RU2226689C2/en
Application granted granted Critical
Publication of RU2226689C2 publication Critical patent/RU2226689C2/en
Publication of RU2001135360A publication Critical patent/RU2001135360A/en

Links

Claims (1)

Способ определения сопротивляемости организма путем анализа форменных элементов периферической крови, отличающийся тем, что вначале определяют весовые коэффициенты для форменных элементов крови, затем задают интегральный показатель крови (ИПК), равный произведению весовых коэффициентов и при ИПК>1,0 характеризуют как зону повышенной сопротивляемости (адаптационной реакции) организма, 0,6<ИПК<1,0 - зона пониженной сопротивляемости организма и при ИПК<0,6 зона риска.A method for determining the body's resistance by analyzing the formed elements of peripheral blood, characterized in that the weight coefficients for the formed blood elements are first determined, then the integral blood indicator (IPC) is set equal to the product of the weight coefficients and is characterized as a zone of increased resistance (IPC> 1.0) ( adaptive reaction) of the body, 0.6 <IPC <1.0 - zone of lowered body resistance and with IPC <0.6 risk zone.
RU2001135360/14A 2001-12-27 2001-12-27 Method for determining organism resistibility RU2226689C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2001135360/14A RU2226689C2 (en) 2001-12-27 2001-12-27 Method for determining organism resistibility

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2001135360/14A RU2226689C2 (en) 2001-12-27 2001-12-27 Method for determining organism resistibility

Publications (2)

Publication Number Publication Date
RU2226689C2 RU2226689C2 (en) 2004-04-10
RU2001135360A true RU2001135360A (en) 2004-04-20

Family

ID=32464930

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2001135360/14A RU2226689C2 (en) 2001-12-27 2001-12-27 Method for determining organism resistibility

Country Status (1)

Country Link
RU (1) RU2226689C2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102834048B (en) * 2010-03-05 2016-03-30 B.布朗梅尔松根公司 Consider important individual factor, for outpatients for drug the system for the data of determining associated therapy
RU2637107C2 (en) * 2015-11-13 2017-11-29 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский радиологический центр" Министерства здравоохранения Российской Федерации" (ФГБУ "НМИРЦ" Минздрава России) Method for assessment of humoral homeostasis state in oncological patients

Similar Documents

Publication Publication Date Title
WO2005099716A3 (en) Method for analyzing the biological age of a subject
WO2003097121A3 (en) &#39;biosensor for dialysis therapy&#39;
GB2413078B (en) A system or method for assessing a subject&#39;s pedal blood circulation
WO2003047690A3 (en) Dual chamber method and apparatus for diagnosis and treatment of arrhythmias
WO2002069796A3 (en) Correction of spectra for subject diversity
HK1091129A1 (en) Food for improving clinical conditions capable of lowering the concentration of low-molecular-weightnitrogen-containing compounds in blood
HUP0501108A3 (en) Treatment of muscular dystrophy with cord blood cells
RU2001135360A (en) METHOD FOR DETERMINING AN ORGANISM RESISTANCE
WO2003054166A3 (en) Nucleotide polymorphisms associated with osteoarthritis
EP0895748A3 (en) Patient monitoring apparatus
WO2003064471A3 (en) Gene for peripheral arterial occlusive disease
PL354641A1 (en) Method of lowering the unfeed blood sugar level and increasing body weight with diabetics
Keskinen et al. Effect of pool length on biomechanical performance in front crawl swimming
WO2002056666A3 (en) A method of detecting ultrasound contrast agent in soft tissue, and quantitating blood perfusion through regions of tissue
WO2002072551A3 (en) A non-traumatic model for neurogenic pain
Branch Effects of exercise training intensity and mode on erythrocyte volume and total hemoglobin in adult females.
RU2001133138A (en) A method for the diagnosis of kidney condition in newborns
UA67500A (en) Method for assessing adaptation potential of cardiovascular system
RU2001117161A (en) METHOD FOR EVALUATING THE CONDITIONS OF NEWBORNS WITH INNEROPETAL INFECTION
RU2019101574A (en) Method for determining the degree of violation of the evacuation function of the stomach in patients with cicatricial-ulcerative pyloroduodenal stenosis
WO2001080712A3 (en) Method of determining a risk of hyperglycemic patients of developing a cardiovascular disease
Adebisi et al. Serum protein fractions of Nigerians with Plasmodium infections: Ilorin experience
FI881678A (en) FAESTANORDNING.
RU93031901A (en) DRY NON-ALCOHOL DRINK &#34;MALT&#34;
UA31748A (en) Method for predicting course of hypertension